SR&ED for Life Sciences and Biotech (2024 Guide)

Life sciences companies—pharmaceuticals, biotechnology, medical devices, and diagnostics—are among the most R&D-intensive industries and natural candidates for significant SR&ED claims. The systematic experimentation inherent in drug development, device design, and biological research aligns well with SR&ED criteria.

SR&ED Opportunity in Life Sciences

Why Life Sciences Claims Are Strong

R&D-intensive by nature—often 15-25% of revenue on research
Well-documented experimentation (GLP, quality systems)
Clear technological uncertainties
Claims commonly range from $200,000 to $2M+
Refundable credits critical for capital-intensive research

What Life Sciences Work Qualifies

Pharmaceutical Development

Eligible:

Drug discovery and lead optimization
Formulation development with uncertain outcomes
Drug delivery system innovation
Process chemistry development
Analytical method development

Gray area: Clinical trials (typically NOT eligible—testing known compounds)

Biotechnology

Eligible:

Protein/antibody engineering
Genetic modification and gene therapy development
Bioprocess development and optimization
Assay development
Platform technology development

Medical Devices

Eligible:

Device design with technical challenges
Biocompatibility experimentation
Novel sensor or component development
Software development for devices (with technical uncertainty)
Manufacturing process development

Diagnostics

Eligible:

New assay development
Biomarker discovery
Platform development
Sensitivity/specificity optimization

Not Eligible

Routine clinical trials
Manufacturing validation (post-development)
Regulatory submission documentation
Quality control testing
Literature reviews without experimentation

Life Sciences SR&ED Examples

Example 1: Drug Formulation

Project: Develop oral formulation for poorly soluble API

Uncertainty: Achieving bioavailability >50% without food effect. Existing formulation approaches yielded <20% bioavailability.

Experimentation: Screened 15 excipient combinations, tested spray-dried dispersions, hot-melt extrusion, nanoparticle approaches. Conducted dissolution testing, stability studies, preliminary PK studies.

Advancement: Achieved 65% bioavailability using novel amorphous solid dispersion. Demonstrated stability over 12 months.

Claim value: $380,000

Example 2: Medical Device

Project: Develop continuous glucose monitor with extended wear

Uncertainty: Achieving 14-day sensor life with required accuracy. Biocompatibility and signal drift were unresolved challenges.

Experimentation: Tested 8 sensor membrane configurations, developed calibration algorithms, experimented with electrode materials, conducted biocompatibility studies.

Advancement: Achieved 14-day wear with MARD <10%. Developed novel membrane approach reducing biofouling.

Claim value: $450,000

Example 3: Bioprocess Optimization

Project: Increase monoclonal antibody titer 3x while maintaining quality

Uncertainty: Higher titer formulations showed aggregation. No established approach achieved target with acceptable quality.

Experimentation: Tested 20+ media formulations, varied feed strategies, experimented with process parameters (pH, temperature, DO). Analyzed glycosylation and aggregation profiles.

Advancement: Achieved 4.2x titer improvement with comparable quality profile. Developed novel feed strategy transferable to other products.

Claim value: $275,000

Documentation in Life Sciences

Strong Documentation Foundation

Life sciences typically has excellent documentation:

Lab notebooks (often GLP)
Experimental protocols
Batch records
Analytical data
Development reports

Leverage what you have for SR&ED—you're likely already documenting properly.

Key Documentation

Experimental rationale and hypotheses
Study protocols and results
Formulation/process development records
Analytical method development
Scale-up studies
Failure analysis and iteration

Expenditure Considerations

Salaries

Eligible roles:

Research scientists
Formulation scientists
Process development engineers
Analytical scientists
Device engineers
Regulatory affairs (when developing novel approaches)

Materials

Often significant:

APIs and excipients for development
Cell culture media and reagents
Device prototyping materials
Reference standards
Biological materials

Capital Equipment

Common:

Laboratory equipment used primarily for R&D
Analytical instruments for development
Scale-down equipment
Prototyping equipment

Contractors

CRO fees for SR&ED work
Specialized testing services
Consulting for technical challenges

Clinical Trials and SR&ED

Generally NOT Eligible

Clinical trials typically test known compounds on humans—this doesn't meet technological uncertainty criteria.

When Portions May Qualify

Novel clinical trial methodologies with technical challenges
Biomarker development for patient stratification
Analytical method development for clinical samples
Software/algorithm development for trial analysis

Conservative approach recommended for clinical trial claims.

Maximizing Life Sciences SR&ED

1. Claim Early-Stage Work

Drug discovery and lead optimization
Formulation screening
Process development
Device design iterations

2. Include Failed Experiments

Drug development has high failure rates. Failed experiments are strong SR&ED evidence—you tested hypotheses and learned.

3. Track Scientist Time by Project

Allocate time to specific development programs and activities.

4. Include All Development Materials

Development-stage materials are often substantial—don't overlook these costs.

Work with Specialized Life Sciences Consultants

Life sciences companies need consultants who understand:

Drug/device development processes
GLP documentation requirements
Formulation and bioprocess development
Regulatory context and SR&ED eligibility boundaries
Capital equipment used for R&D

See our detailed guide on How to Choose an SR&ED Consultant →

Browse Consultants by Service

Life sciences companies typically benefit from:

Claim Preparation Services - End-to-end claim preparation
Technical Documentation Services - Converting lab work into compelling narratives
Financial Analysis Services - Optimizing materials and equipment costs
Eligibility Assessment Services - Determining what development qualifies

Find Life Sciences SR&ED Specialists →

Frequently Asked Questions

Are clinical trials eligible?

Generally no—they test known compounds. Some supporting activities may qualify.

What about regulatory submissions?

Documentation for submissions isn't eligible, but the underlying R&D is.

Can contract research organization (CRO) fees be claimed?

Yes, 80% of arm's-length CRO fees for SR&ED work are eligible.

Is formulation development always eligible?

When there's genuine technological uncertainty requiring experimentation, yes. Routine formulation work doesn't qualify.

What about quality system work?

Quality system development may qualify if it involves technical innovation. Routine QC doesn't.

Next Steps

Review drug/device development programs for SR&ED eligibility
Identify formulation, process, and analytical development projects
Ensure lab notebooks document uncertainties and hypotheses
Track scientist time by project
Connect with life sciences SR&ED specialists

Find Life Sciences SR&ED Specialists →

Last updated: November 2024. Consult a qualified SR&ED professional for your specific situation.